Zentalis Pharmaceuticals (ZNTL) Times Interest Earned (2019 - 2026)
Zentalis Pharmaceuticals' (ZNTL) quarterly Times Interest Earned came in at -$0.73 in Q1 2026, up 5.53% year-on-year from -$0.69 in Q1 2025, and up 99.98% quarter-over-quarter from -$3399.4 in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) Times Interest Earned (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Times Interest Earned history runs 8 years deep, the most recent figure standing at -$0.73 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 5.53% year-over-year to -$0.73 in Q1 2026; TTM through Mar 2026 was -$2.81, a 22.13% increase from a year earlier, with the FY2025 full-year figure at -$22.47, down 2803.38% from the prior year.
- Times Interest Earned improved to -$0.73 in Q1 2026 per ZNTL's latest filing, from -$3399.4 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.2 in Q4 2024 and bottomed at -$3399.4 in Q4 2025.
- The 5-year median for Times Interest Earned is -$1.25 (2023), against an average of -$215.15.
- Across the five-year window, Times Interest Earned soared 98.95% in 2022 and tumbled 1684442.92% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$0.73 in 2022, then plunged by 1354.03% to -$10.61 in 2023, then surged by 98.1% to -$0.2 in 2024, then tumbled by 1684442.92% to -$3399.4 in 2025, then surged by 99.98% to -$0.73 in 2026.
- Per Business Quant, the three latest ZNTL Times Interest Earned figures stand at -$0.73 (Q1 2026), -$3399.4 (Q4 2025), and -$2.27 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Zentalis Pharmaceuticals | 312.67 Mn | 312.67 Mn | - | -0.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.73 |
| Dec 31, 2025 | -3,399.36 |
| Sep 30, 2025 | -2.27 |
| Jun 30, 2025 | -0.63 |
| Mar 31, 2025 | -0.78 |
| Dec 31, 2024 | -0.20 |
| Sep 30, 2024 | -2.76 |
| Jun 30, 2024 | -1.02 |
| Mar 31, 2024 | -0.37 |
| Dec 31, 2023 | -10.61 |
| Sep 30, 2023 | -0.92 |
| Jun 30, 2023 | -1.48 |
| Mar 31, 2023 | -2.63 |
| Sep 30, 2022 | -0.73 |
| Jun 30, 2022 | -9.33 |
| Mar 31, 2022 | -8.51 |
| Sep 30, 2021 | -69.24 |
| Jun 30, 2021 | -47.08 |
| Mar 31, 2021 | -30.62 |
| Dec 31, 2020 | -0.71 |